GEVA has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Synageva BioPharma Corp's quarterly other liabilities (bank) increased from Mar. 2014 ($5.57 Mil) to Jun. 2014 ($5.99 Mil) and increased from Jun. 2014 ($5.99 Mil) to Sep. 2014 ($6.12 Mil).
Synageva BioPharma Corp's annual other liabilities (bank) increased from Dec. 2011 ($2.74 Mil) to Dec. 2012 ($5.39 Mil) but then declined from Dec. 2012 ($5.39 Mil) to Dec. 2013 ($4.06 Mil).
Other liabilities that banks have. For insurance companies, it means other liabilities that insurance companies have.
As used by the bank, this category may include numerous accounts not included under other specific liability categories. In some banks, individual accounts are established for control purposes and appear as other liabilities on the balance sheet.
* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.
Synageva BioPharma Corp Annual Data
Synageva BioPharma Corp Quarterly Data